Summary
This 8-K filing from Johnson & Johnson details significant corporate governance changes approved by shareholders at their 2020 Annual Meeting. The most impactful change for investors is the approval of an amendment to the Restated Certificate of Incorporation, allowing shareholders to remove directors without cause. This shifts the power balance and enhances director accountability. Additionally, the company's By-Laws were amended to allow for remote shareholder meetings and to grant the Board more flexibility in scheduling or canceling annual meetings. These changes reflect a move towards greater corporate governance flexibility and responsiveness.
Key Highlights
- 1Shareholders approved an amendment to the Restated Certificate of Incorporation to permit the removal of directors without cause, increasing board accountability.
- 2The company's By-Laws were amended to enable shareholder meetings to be held partially or solely by remote communication.
- 3Shareholders also granted the Board of Directors the ability to postpone, reschedule, or cancel previously scheduled annual meetings.
- 4All 13 director nominees were elected to the Board.
- 5Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2020.
- 6An advisory vote to approve the executive compensation philosophy and the compensation of named executive officers was passed.
- 7A shareholder proposal for an independent board chair was not approved.